News from SABCS 2025
-
View from the Trenches panelists place SABCS presentations into clinical context
Experts wrapped up the 2025 San Antonio Breast Cancer Symposium by discussing how to translate the week’s presentations into immediate impact for patients and physicians.
-
Special session explores key distinctions, considerations around breast cancer in young women
Panelists reviewed the biological features, treatment decisions, and ethical nuances around young-onset breast cancer.
-
FDA session offers closer look at approval process for HR-positive metastatic breast cancer therapies
Participants discussed regulatory considerations for imlunestrant, datopotamab deruxtecan (Dato-DXd), and trastuzumab deruxtecan (T-DXd).